Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Balko

Showing results (21-30 of 358) with videos related to

Pageof 36
Sort By:
The American Journal of Forensic Medicine and Pathology|July 22, 1999
Sudden death due to a central neurocytomaM G Balko, D L Schultz
The Veterinary Clinics of North America. Exotic Animal Practice|August 8, 2017
Advancements in Evidence-Based Anesthesia of Exotic AnimalsJulie A Balko, Sathya K Chinnadurai
Cancer Cell|March 3, 2023
T cell dynamism and immune-related adverse eventsDouglas B Johnson, Justin M Balko
Frontiers in Immunology|March 17, 2022
Mechanisms of MHC-I Downregulation and Role in Immunotherapy ResponseBrandie C Taylor, Justin M Balko
BMC Cancer|May 15, 2009
A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancerJustin M Balko, Esther P Black
Mikrobiolohichnyi Zhurnal (Kiev, Ukraine : 1993)|June 13, 2012
[Screening of producers of bacteriocin-like substances active against Pseudomonas aeruginosa]A B Balko, L V Avdeeva
Discovery Medicine|June 3, 2014
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancerJennifer M Giltnane, Justin M Balko
Cancer Biology & Therapy|November 26, 2008
Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signatureJustin M Balko, Esther P Black
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?Douglas B Johnson, Justin M Balko
Molecular & Cellular Oncology|September 22, 2016
Maybe we don't know JAK?Luis J Schwarz, Justin M Balko
Pageof 36

Showing results (21-30 of 358) with videos related to

Sort By:
Pageof 36
The American Journal of Forensic Medicine and Pathology|July 22, 1999
Sudden death due to a central neurocytomaM G Balko, D L Schultz
The Veterinary Clinics of North America. Exotic Animal Practice|August 8, 2017
Advancements in Evidence-Based Anesthesia of Exotic AnimalsJulie A Balko, Sathya K Chinnadurai
Cancer Cell|March 3, 2023
T cell dynamism and immune-related adverse eventsDouglas B Johnson, Justin M Balko
Frontiers in Immunology|March 17, 2022
Mechanisms of MHC-I Downregulation and Role in Immunotherapy ResponseBrandie C Taylor, Justin M Balko
BMC Cancer|May 15, 2009
A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancerJustin M Balko, Esther P Black
Mikrobiolohichnyi Zhurnal (Kiev, Ukraine : 1993)|June 13, 2012
[Screening of producers of bacteriocin-like substances active against Pseudomonas aeruginosa]A B Balko, L V Avdeeva
Discovery Medicine|June 3, 2014
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancerJennifer M Giltnane, Justin M Balko
Cancer Biology & Therapy|November 26, 2008
Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signatureJustin M Balko, Esther P Black
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 28, 2018
Biomarkers for Immunotherapy Toxicity: Are Cytokines the Answer?Douglas B Johnson, Justin M Balko
Molecular & Cellular Oncology|September 22, 2016
Maybe we don't know JAK?Luis J Schwarz, Justin M Balko
Pageof 36